DIA: Driving Insights to Action

US Generic Drug Policy: Less Cost, Same Impact

February 28, 2018

Maryll Toufanian, JD, Acting Director, US FDA Office of Generic Drug Policy, discusses the US FDA’s Drug Competition Action Plan, why US consumers can feel safe taking generic drugs, and how generic drugs can help reduce costs for healthcare patients and systems. Learn more at our Complex Drug-Device Generic Combination Products conference.

Podbean App

Play this podcast on Podbean App